Skip to main content

Day: December 30, 2025

Prairie Provident Announces Share Consolidation

CALGARY, Alberta, Dec. 30, 2025 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident” or the “Company”) (TSX:PPR) announces that, further to the special resolution of Prairie Provident shareholders passed at the annual and special meeting of shareholders held May 22, 2025, the Company will implement a 30-to-1 consolidation of its outstanding common shares (the “Consolidation”), on the basis of one post-Consolidation common share for every 30 pre-Consolidation common shares. The Consolidation will be effective December 31, 2025 (the “Effective Date”). The Toronto Stock Exchange (“TSX”) has accepted notice of the Consolidation, and the common shares of Prairie Provident are expected to begin trading on TSX on a post-Consolidation basis two to three trading...

Continue reading

Opus One Gold Corporation Announces Closing of a Private Placement of Flow-Through Shares and Units

MONTREAL, Dec. 30, 2025 (GLOBE NEWSWIRE) — Opus One Gold Corporation (OOR: TSXV) (“Opus One Gold” or the “Company”), is pleased to announce the closing of a non-brokered private placement of flow-through shares (“FT Shares”) and units of the Company (the “Units”) for aggregate gross proceeds of $2,228,825.31 (the “Offering”). In total, the Company issued 21,014,338 FT Shares for gross proceeds of $1,576,075.35 at a price per FT Share of $0.075 and 10,042,307 Units for gross proceeds of $652,749.96 at a price per Unit of $0.065, with each Unit being comprised of one common share of the Company (a “Share”) and one common share purchase warrant (each a “Warrant”, and together, the “Warrants”), with each Warrant entitling the holder to acquire one common share (each a “Warrant Share”) at an exercise price of $0.10 per Share for a period...

Continue reading

Cannabix Secures First Distributor Order for BreathLogix Alcohol Screening Devices in Australia

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) a developer of marijuana and alcohol breath testing devices, is pleased to announce that it has received its first product orders for BreathLogix devices and related accessories from its exclusive distribution partner in Australia, Breathalyser Sales & Service Pty Ltd. (“Breathalyser SSP”). This order represents Cannabix’s first international distributor order for its BreathLogix alcohol screening product line. Earlier this year, Cannabix entered into an exclusive distribution agreement with Breathalyser SSP for Australia, New Zealand,...

Continue reading

Atlantic Petroleum -Financial Calendar 2026 correction

Tórshavn, Faroe Islands, 2025-12-30 (GLOBE NEWSWIRE) — P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) hereby announces the financial calendar for 2026 with the following dates:Tuesday 31st March: Annual Accounts 2025 to be issued. Thursday 30th April: Annual General Meeting. Friday 29th May: 1st Quarter 2026 Condensed Consolidated Interim Report to be issued. Monday 31st August: 2nd Quarter 2026 Condensed Consolidated Interim Report to be issued. Monday 30th November: 3rd Quarter 2026 Condensed Consolidated Interim Report to be issued. Atlantic Petroleum in brief: Atlantic Petroleum participates in oil and gas joint ventures with reputable, international partners. Atlantic Petroleum P/F is based in Tórshavn, Faroe Islands, and the Company has subsidiaries and offices in the UK and Ireland. Atlantic Petroleum’s shares are listed...

Continue reading

Vivakor Resets Payment Date of Special Dividend to April 30, 2026

Dallas, TX, Dec. 30, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation services today announced that it has reset the payment date of its previously announced special dividend to Vivakor shareholders to April 30, 2026. The payment date adjustment is intended to allow the Company sufficient time to complete required filings with the U.S. Securities and Exchange Comission in connection with the consummation of the special dividend. The filing process was impacted by delays associated with the recent government shutdown. The Company notes that the payment date may be subject to further adjustement if the required filings are not completed in a timely manner. The special dividend will be paid to holders of record of Vivakor...

Continue reading

Atlantic Petroleum -Financial Calendar 2026

Tórshavn, Faroe Islands, 2025-12-30 (GLOBE NEWSWIRE) — P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) hereby announces the financial calendar for 2026 with the following dates:Tuesday 31st March: Annual Accounts 2024 to be issued. Thursday 30th April: Annual General Meeting. Friday 29th May: 1st Quarter 2025 Condensed Consolidated Interim Report to be issued. Monday 31st August: 2nd Quarter 2025 Condensed Consolidated Interim Report to be issued. Monday 30th November: 3rd Quarter 2025 Condensed Consolidated Interim Report to be issued. Atlantic Petroleum in brief: Atlantic Petroleum participates in oil and gas joint ventures with reputable, international partners. Atlantic Petroleum P/F is based in Tórshavn, Faroe Islands, and the Company has subsidiaries and offices in the UK and Ireland. Atlantic Petroleum’s shares are listed...

Continue reading

AIM ImmunoTech Announces Stock Dividend

OCALA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) —  AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of outstanding common stock as well as one share of common stock for every outstanding option or warrant that has a right to receive stock dividends (“Alternate Securities”). The dividend will be issuable to stockholders and Alternate Securities holders of record at the close of business on January 9, 2026 and will be distributed and allocated to DTCC on January 13, 2026. Resulting fractional shares will be rounded down and any resulting fractional shares remaining after the foregoing rounding down will be distributed cash to each stockholder and Alternate Securities holder who would otherwise have been entitled to receive such fractional...

Continue reading

AYR Wellness Announces Leadership Update

MIAMI, Dec. 30, 2025 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that Donna Granato, the Company’s interim Chief Financial Officer (“CFO”), will depart AYR December 31, 2025. AYR Interim CEO Blake Holzgrafe said, “As we continue the orderly wind down of AYR’s existing corporate entity and transition the Company’s go-forward assets to the new AYR, we thank Donna for her contributions to the Company.” Scott Davido, former interim CEO of AYR said, “Donna stepped in during a period of significant complexity and uncertainty for the Company. Her leadership, judgment, and commitment were instrumental in helping guide the business through the initial, critical phases of our debt restructuring and ownership transition....

Continue reading

Stallion Uranium Announces Increase to Flow-Through Financing and Completes Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce that, further to its news releases dated December 12, 2025 and December 17, 2025, it has increased its non-brokered private placement to raise gross proceeds of $7,723,064 (the “Offering”). The Company also announces that it has closed the Offering, issuing 17,162,365 flow-through shares of the Company as a “flow-through share” within the meaning of the Income Tax Act (Canada) (each, a “FT Share”) at a price of $0.45 per FT Share. The gross proceeds from the FT Shares will be used by the Company to incur eligible “Canadian exploration expenses” that qualify...

Continue reading

Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2025

TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) — TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited interim consolidated financial results for the three and nine month periods ended September 30, 2025. Financial HighlightsTotal assets as of September 30, 2025 amounted to approximately €759.4 million, compared to total assets as of December 31, 2024 of approximately €677.3 million. Revenues1 for the three months ended September 30, 2025 were approximately €12.7 million, compared to revenues of approximately €12.3 million for the three months ended September 30, 2024. Revenues for the nine months...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.